Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Gov't to Formulate Basic Policy for New Healthcare System for Elderly in FY2002
March 11, 2002
- NCC Forecasts Survival Rates for Cancer Will Double by 2015
March 11, 2002
- Each Drug Firm Has Tie-ups with 18 Others: FTC Survey
March 11, 2002
- Novartis Foundation Provides Support for 53 Researchers
March 11, 2002
- REGULATORY NEWS IN BRIEF
March 11, 2002
- DIAGNOSTIC NEWS IN BRIEF
March 11, 2002
- OTS NEWS IN BRIEF
March 11, 2002
- NHI Price Revision in April Will Hit Drug Companies Hard: Mr Fujiyama of FPMAJ
March 11, 2002
- Kuraya Sanseido Aims at Consolidated Sales of \1,330 Bil. in FY2004
March 11, 2002
- GE Maker Lost the Game: Mr Sawai
March 11, 2002
- Hokuriku: Sales Increase by 22% to \24.9 Bil.
March 11, 2002
- New SMO Industry Organization to Be Created in April
March 11, 2002
- Otsuka's POCARI Drink Inhibits Increases in Blood Viscosity
March 11, 2002
- SSRI 20th Anniversary Seminar
March 11, 2002
- Sunstar to Report Anti-allergic Effects of Persimmon Leaf Extract
March 11, 2002
- RAD-AR Proposes to Korosho to Use Reexamination Data to Construct Database
March 11, 2002
- Glaucoma Testing Not Conducted in 80% of Municipalities in Tokyo
March 11, 2002
- BUSINESS NEWS IN BRIEF
March 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 11, 2002
- 7 Drugs Approved, Including Sivelestat
March 11, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…